Amphetamine induced dopamine release increases anxiety in individuals recovered from anorexia nervosa

Int J Eat Disord. 2012 Mar;45(2):263-71. doi: 10.1002/eat.20937. Epub 2011 May 3.

Abstract

Objective: Genetic, pharmacologic, and physiological data suggest that individuals with anorexia nervosa (AN) have altered striatal dopamine (DA) function.

Method: We used an amphetamine challenge and positron emission tomography [(11) C]raclopride paradigm to explore DA striatal transmission in 10 recovered (REC) AN compared with 9 control women (CW).

Results: REC AN and CW were similar for baseline, postamphetamine [(11) C]raclopride binding potential (BP(ND) ) and change (Δ) in BP(ND) for all regions. In CW, ventral striatum Δ BP(ND) was associated with euphoria (r = -0.76; p = 0.03), which was not found for REC AN. Instead, REC AN showed a significant relationship between anxiety and Δ BP(ND) in the precommissural dorsal caudate (r = -0.62, p = 0.05).

Discussion: REC AN have a positive association between endogenous DA release and anxiety in the dorsal caudate. This finding could explain why food-related DA release produces anxiety in AN, whereas feeding is pleasurable in healthy participants.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amphetamine / pharmacology*
  • Anorexia Nervosa / diagnostic imaging
  • Anorexia Nervosa / metabolism
  • Anorexia Nervosa / psychology*
  • Anxiety / diagnostic imaging
  • Anxiety / metabolism*
  • Anxiety / psychology
  • Corpus Striatum / diagnostic imaging
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dopamine / metabolism*
  • Dopamine Agents / pharmacology*
  • Euphoria / drug effects
  • Euphoria / physiology
  • Female
  • Humans
  • Radionuclide Imaging

Substances

  • Dopamine Agents
  • Amphetamine
  • Dopamine